Skip to content

effect of multidimensional treatment based on biopsychosocial approach in chronic non specific low back pain

Effect of multidimensional physiotherapy treatment based on biopsychosocial approach on clinical findings and electroencephalography spectrum in chronic nonspecific low back pain: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140810018754N11
Enrollment
70
Registered
2020-01-17
Start date
2020-04-05
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-specific chronic low back pain. Low back pain

Interventions

Intervention 1: Patients in the intervention group will be received multidimensional treatment include psychoeducation based on cognitive behavioral therapy (CBT), education, graded exposure, postural

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age between 18-50 Permanent or intermittent local pain between L1 to gluteal fold without any radicular pain for 3 months or more and between 3-7/10 based on Numeric Rating Scale (NRS) Disability based on Oswestry Disability Index (ODI) between 20-60 Fear of movement based on Tampa scale for kinesiophobia>37 Minimum level of education Native Persian speaking

Exclusion criteria

Exclusion criteria: Any evidence of e specific medical diagnosis include spondylolisthesis, fracture, tumor or inflammation disease Rheumatoid disease,fibromyalgia, neuropathy, Progressive neurological disease History of headache, dizziness, nausea, epilepsy, migraines and mental disorders History of lumbar surgery in the past 3 years Beck’s Anxiety Inventory> 26 Beck's Depression Inventory II> 29 Pregnancy Having other therapies during the present research

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before the study, end of 6 weeks of treatment, 1 and 4 months follow-up. Method of measurement: Numeric Rating Scale.

Secondary

MeasureTime frame
Fear Avoidance Believes. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Fear Avoidance Believes questionnaire.;Kinesiophobia. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Tampa scale of kinesiophobia.;Pain Catastrophizing. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Pain Catastrophizing Scale.;Disability. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Oswestry disability scalequestionnaire.;Forward flexion ROM. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Tape.;Absolute power of frequency spectrum. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Electroencephalography.;Relative power of the frequency spectrum. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Electroencephalography.;Quality of Life. Timepoint: Before study, end of 6 weeks treatment, 1 and 4 months follow-up. Method of measurement: Sf36 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJavad Sarrafzadeh

Iran University of Medical Sciences

sarrafzadeh.j@iums.ac.ir+98 21 2222 8051

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 21, 2026